glp 1 gip triple agonist retatrutide mechanism glp-1 glucagon Treatment with retatrutide, an agonist to GLP-1 LY3437943, a novel triple glucagon,
Description
doi: 10.1136/bmj.h56 78 HankeyGJ
The clustering of Cardiovascular, Renal, Adipo-Metabolic Eye and Liver disease with type 2 diabetes
A., & Gooley, J
Understanding the mechanisms underlying these cardiovascular benefits is crucial for optimizing the treatment of T2D
Start with a lower dose than patients reported compounded drug dose and titrate up slowly, Basina said
